These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19191866)

  • 21. Antilymphocyte globulin for myelodysplastic syndrome.
    Tichelli A; Gratwohl A; Wuersch A; Nissen C; Speck B
    Br J Haematol; 1988 Jan; 68(1):139-40. PubMed ID: 3345291
    [No Abstract]   [Full Text] [Related]  

  • 22. Interference by heterophilic antibodies in immunoassays: wrong increase of myoglobin values.
    Bonetti A; Monica C; Bonaguri C; Gnocchi C; Russo A; Battistelli L; Musiari L; Pastori P; Novarini A
    Acta Biomed; 2008 Aug; 79(2):140-3. PubMed ID: 18788511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Action of antilymphocyte globulin on the lymphoid cells of patients with hypoplastic anemia].
    Serova LD; Shliapochnikova GP
    Sov Med; 1978 Aug; (8):20-6. PubMed ID: 705450
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of fibrinogen degradation products in rheumatic diseases].
    Murav'ev IuV
    Ter Arkh; 1980; 52(6):84-7. PubMed ID: 7404395
    [No Abstract]   [Full Text] [Related]  

  • 25. A method for routine detection of heterophile antibody interference in the Abbott AxSYM hCG assay.
    Jones GR; Giannopoulos P
    Pathology; 2004 Aug; 36(4):364-6. PubMed ID: 15370140
    [No Abstract]   [Full Text] [Related]  

  • 26. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J; Tutor JC
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
    Kwiecien-Głowacka E
    Przegl Lek; 1981; 38(3):335-40. PubMed ID: 7244292
    [No Abstract]   [Full Text] [Related]  

  • 28. D-dimer assays: the current status and new assay technologies.
    Dempfle CE
    Thromb Res; 2006; 118(5):569-71. PubMed ID: 16139335
    [No Abstract]   [Full Text] [Related]  

  • 29. Heterophilic antibody interference in an ultra-sensitive 3-site sandwich troponin I immunoassay.
    Zhu Y; Jenkins MM; Brass DA; Ravago PG; Horne BD; Dean SB; Drayton N
    Clin Chim Acta; 2008 Sep; 395(1-2):181-2. PubMed ID: 18503763
    [No Abstract]   [Full Text] [Related]  

  • 30. Unnecessary coronary angiography due to false positive troponin I results in a 51-year-old man.
    Bionda C; Rousson R; Collin-Chavagnac D; Manchon M; Chikh K; Charrié A
    Clin Chim Acta; 2007 Mar; 378(1-2):225-6. PubMed ID: 17187769
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative fibrinogen determination by artificial in vitro fibrinogen lysis with regard to fibrinogen split products].
    Kätzel R; Brunner HP; Bohr A
    Z Med Lab Diagn; 1981; 22(3):138-43. PubMed ID: 7293326
    [No Abstract]   [Full Text] [Related]  

  • 32. Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.
    Coca A; Bundy KW; Marston B; Huggins J; Looney RJ
    Clin Immunol; 2009 Jul; 132(1):10-8. PubMed ID: 19297252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-dimer measurement and laboratory feedback.
    Lippi G; Favaloro EJ
    J Emerg Med; 2009 Jul; 37(1):82-3; author reply 83. PubMed ID: 19168310
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fibrinogen degradation products in diabetes mellitus].
    Bondar PN
    Vrach Delo; 1981 Oct; (10):80-1. PubMed ID: 7303588
    [No Abstract]   [Full Text] [Related]  

  • 35. [Discrepancy between two methods of D-dimers measurement: one case of human anti-mouse antibody interference].
    Rouvière JA; Devignes J; de Maistre E; Kennel A; Chabot F; Lecompte T
    Ann Biol Clin (Paris); 2008; 66(4):441-6. PubMed ID: 18725347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Products of fibrinogen degradation in cirrhotic ascites. Value of their assay].
    Hadchouel P; Bognel JC; Caillet R; Perotin B; Hebert D
    Nouv Presse Med; 1980 Jun; 9(26):1844. PubMed ID: 7393737
    [No Abstract]   [Full Text] [Related]  

  • 37. [Examination of fibrin degradation products in cirrhosis of liver (author's transl)].
    Pstruzinová H; Rovenská A; Goderová Z; Kristan M
    Cas Lek Cesk; 1980 Jan; 119(1):7-11. PubMed ID: 7371051
    [No Abstract]   [Full Text] [Related]  

  • 38. Myelodysplastic syndrome and pregnancy: case report.
    Sackmann Massa F; Pavlovsky S
    Leuk Res; 2009 Mar; 33(3):e23-5. PubMed ID: 18684504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of fibrinogen and its degradation products with staphylococcal diagnosticum (review of the literature)].
    Lapaeva EE
    Lab Delo; 1981; (5):304-7. PubMed ID: 6169893
    [No Abstract]   [Full Text] [Related]  

  • 40. Harmonisation of D-dimer - A call for action.
    Longstaff C; Adcock D; Olson JD; Jennings I; Kitchen S; Mutch N; Meijer P; Favaloro EJ; Lippi G; Thachil J
    Thromb Res; 2016 Jan; 137():219-220. PubMed ID: 26620264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.